The Women's Cardio-Metabolic Axis

A Healing Heart Medical is a dedicated clinic for the intersection of cardiovascular and metabolic health. We move beyond symptom management to audit hormonal shifts that drive arterial aging.

Start Your Metabolic Audit

Metabolic Function (% of Peak) Cardiovascular Risk Index 253545 55657585+ Patient Age (Years)
Oestrogen
Progesterone
Cardiovascular Risk
Insulin Sensitivity
Melatonin
Testosterone

Clinical Awareness Zones

Unlike men, a woman's hormonal transition is non-linear. Standard medicine often misses the silent metabolic changes occurring decades before a cardiac event. At A Healing Heart Medical, Singapore’s first integrated Cardio-Metabolic clinic, we specialize in auditing these critical 'handoff' windows.

Zone 1: The Silent Decade

PRE-MENOPAUSE (Ages 35–45)

The metabolic groundwork is laid here. While you feel well, Insulin Sensitivity begins its silent decline. This is the most critical window for intervention before the vascular shield starts to thin.

Zone 2: The Hormonal Storm

PERIMENOPAUSE (Ages 45–53)

The "Critical Handoff." Oestrogen becomes volatile and Progesterone drops steeply. Cardiovascular risk hits its steepest inflection point as your internal protection is dismantled.

Zone 3: The Metabolic Trap

POST-MENOPAUSE (Ages 55+)

Hormones stabilize at a low baseline. Cardiovascular Risk now dominates the axis. Stewardship shifts to active management of lipids, blood pressure, and regenerative metabolic health.

Cardio-Metabolic Health FAQ

Why is Oestrogen called a "Vascular Shield"?
Oestrogen is a powerful anti-inflammatory that protects a woman's arterial walls. When levels fluctuate and fall during perimenopause, this "shield" is removed, often causing a rapid decline in Insulin Sensitivity. We specialize in auditing this transition to ensure your metabolic health doesn't leave your heart vulnerable as your hormones shift.


How does this differ from a standard health screening?
Most screenings look for established disease (like high blood pressure, high cholesterol, and high sugar level). Our audit is designed for early-stage prevention. By identifying "silent" insulin resistance and hormonal imbalances decades before a cardiac event occurs, we provide a window for proactive stewardship rather than reactive, lifelong medication.

Men's Version